Early vs conventional initiation of adjuvant chemotherapy in advanced gastric cancer: A propensity-matched outcomes study

Table 3 Site of first recurrence in each treatment group, n (%)

Site	Conventional (n = 42)	Early (n = 21)	HR for recurrence in the early group (95%CI)	P value	P value1
Total number of relapses	16 (38.1)	9 (42.9)
Local	3 (7.1)	3 (14.3)	2.336 (0.470-11.603)	0.299	0.391
Lymph nodes	3 (7.1)	2 (9.5)	1.459 (0.244-8.733)	0.679	1.000
Hematogenous	4 (9.5)	2 (9.5)	1.636 (0.336-7.312)	0.520	0.677
Peritoneum	11 (26.2)	1 (4.8)	0.418 (0.093-1.887)	0.257	0.048

¹Fisher’s exact test.

Some patients experienced recurrence at more than one site. HR: Hazard ratio; CI: Confidence interval.